by Stacey Johnson | Jun 13, 2014
. What’s small and blue and brings a smile to your face? No, not a Smurf and I’m not talking about a little blue pill either. It’s the little cartoon guy from Life Technologies and he has a mission for those who are ISSCR-bound (and even those who aren’t). Watch him...
by Sara M. Nolte | Jun 9, 2014
> I recently wrote about the dilemma many cancer stem cell (CSC) researchers face when trying to model their disease of interest in the lab. So assuming a researcher has successfully chosen their model – what happens next? Allow me to introduce to you some of the...
by Lisa Willemse | Jun 6, 2014
> Cycling season is in full gear and for the rapidly growing number of enthusiasts, it means many miles on tarmac and trail, Strava leaderboard competitions and various degrees of obsession with the world’s major races. I’m not much of a road rider...
by Lisa Willemse | Jun 3, 2014
> Bench to beside is a deceptively simple phrase. Only 15 characters and relatively jargon-free (assuming you know what bench and bedside are referring to), it’s rather easy to drop into documents or presentations without compromising space or time limits. And,...
by Stacey Johnson | May 30, 2014
> CCRM’s intrepid communications summer student is back! Erin Sugar gets right to the meat of the issue in today’s Right Turn. Does it leave you hungry for more or salivating with anger? Sometimes, an ordinary encasement of all-beef or pork salami is just not going...
by Nick Dragojlovic | May 26, 2014
> In a recent post on Signals, David Kent made the case for government-funded clinical trials of autologous stem cell therapies, since the lack of proven commercialization models in this area make it difficult to attract private investment. Another way of financing...
by Lisa Willemse | May 23, 2014
> Looking for something to do this weekend? Got something to say or show about stem cells? How about one of following — each of them gives you an opportunity to win and/or gain exposure: Write an essay on “Why I want to go to ISSCR 2014”. Fellow...
by Mark Curtis | May 22, 2014
. Welcome to your Update from the Clinic for the month of April. Athersys provides disappointing interim results for its MultiStem® cell therapy in ulcerative colitis patients. Sernova continues to demonstrate safety and biocompatability of its Cell Pouch technology...
by Lisa Willemse | May 21, 2014
> I’m not an academic, but I’ve been to many scientific conferences and read many more papers over the past 10 years or so. I know how important data is in research. I also know how important it is in communications (where visits, likes or shares are...
by Stacey Johnson | May 16, 2014
. Last November, I wrote about CCRM’s new Regenerative Medicine Video Network and featured an original video with Dr. Stephen Minger, Chief Scientist, Cellular Sciences GE Healthcare Life Sciences in the UK. If you enjoyed his industry perspective and insights on...
Comments